Metropolitan Life Insurance Company (MetLife)’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,493
| Closed | -$94.1K | – | 1646 |
|
|
2024
Q1 | $94.1K | Hold |
3,493
| – | – | ﹤0.01% | 1078 |
|
|
2023
Q4 | $105K | Hold |
3,493
| – | – | ﹤0.01% | 1057 |
|
|
2023
Q3 | $71.6K | Buy |
3,493
+425
| +14% | +$8.71K | ﹤0.01% | 1197 |
|
|
2023
Q2 | $61K | Buy |
3,068
+168
| +6% | +$3.34K | ﹤0.01% | 1311 |
|
|
2023
Q1 | $49.7K | Sell |
2,900
-305
| -10% | -$5.23K | ﹤0.01% | 1397 |
|
|
2022
Q4 | $62.7K | Buy |
3,205
+621
| +24% | +$12.2K | ﹤0.01% | 1333 |
|
|
2022
Q3 | $41.2K | Hold |
2,584
| – | – | ﹤0.01% | 1589 |
|
|
2022
Q2 | $35.6K | Hold |
2,584
| – | – | ﹤0.01% | 1713 |
|
|
2022
Q1 | $41K | Sell |
2,584
-8,301
| -76% | -$132K | ﹤0.01% | 1710 |
|
|
2021
Q4 | $238K | Hold |
10,885
| – | – | ﹤0.01% | 1907 |
|
|
2021
Q3 | $325K | Hold |
10,885
| – | – | ﹤0.01% | 1717 |
|
|
2021
Q2 | $482K | Buy |
10,885
+653
| +6% | +$28.9K | 0.01% | 1550 |
|
|
2021
Q1 | $454K | Sell |
10,232
-384
| -4% | -$17K | 0.01% | 1484 |
|
|
2020
Q4 | $582K | Hold |
10,616
| – | – | 0.01% | 1263 |
|
|
2020
Q3 | $243K | Hold |
10,616
| – | – | ﹤0.01% | 1663 |
|
|
2020
Q2 | $222K | Hold |
10,616
| – | – | ﹤0.01% | 1725 |
|
|
2020
Q1 | $148K | Hold |
10,616
| – | – | ﹤0.01% | 1777 |
|
|
2019
Q4 | $242K | Hold |
10,616
| – | – | ﹤0.01% | 1782 |
|
|
2019
Q3 | $124K | Buy |
10,616
+2,519
| +31% | +$29.3K | ﹤0.01% | 2179 |
|
|
2019
Q2 | $121K | Buy |
8,097
+694
| +9% | +$10.4K | ﹤0.01% | 2207 |
|
|
2019
Q1 | $130K | Hold |
7,403
| – | – | ﹤0.01% | 2172 |
|
|
2018
Q4 | $110K | Hold |
7,403
| – | – | ﹤0.01% | 2212 |
|
|
2018
Q3 | $182K | Buy |
+7,403
| New | +$182K | ﹤0.01% | 2065 |
|